IndraLab

Statements

Paclitaxel activates USP7. 6 / 6
| 6
reach
"An intricate study revealed that cisplatin and paclitaxel activate USP7, prompting CAFs to emit exosomal miR-522."
38702734
reach
"Haiyang Zhang et al. found that cisplatin and paclitaxel promote miR-522 secretion from CAFs by activating the USP7/hnRNPA1 axis."
37065473
reach
"Paclitaxel and cisplatin promote miR-522 secretion from cancer-associated fibroblasts by activating USP7/hnRNPA1 axis, leading to arachidonate lipoxygenase 15 suppression and decreased lipid-ROS accumulation in cancer cells and ultimately promote acquired chemoresistance in gastric cancer (Zhang et al., 2020a)."
33967786
reach
"There is a study that suggested that cisplatin and paclitaxel promote miR-522 secretion from cancer-associated fibroblasts by activating the USP7/hnRNPA1 axis, leading to arachidonate lipoxygenase 15 suppression and decreased lipid-ROS accumulation in cancer cells, and ultimately resulting in decreased chemo-sensitivity [37]."
| PMC
reach
"Importantly, cisplatin and paclitaxel promote miR-522 secretion from CAFs by activating USP7/hnRNPA1 axis, leading to ALOX15 suppression and decreased lipid-ROS accumulation in cancer cells, and ultimately result in decreased chemo-sensitivity."
32106859
reach
"Cisplatin and paclitaxel activated the USP7/hnRNPA1 axis to upregulation of RNPA1 protein expression in GC cells."
38030125